Form 8-K - Current report:
SEC Accession No. 0001104659-20-002674
Filing Date
2020-01-09
Accepted
2020-01-09 16:06:24
Documents
2
Period of Report
2020-01-09
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm201562d1_8k.htm 8-K 17838
2 EXHIBIT 99.1 tm201562d1_ex99-1.htm EX-99.1 37244
  Complete submission text file 0001104659-20-002674.txt   56466
Mailing Address 700 TECHNOLOGY DRIVE PITTSBURGH PA 15219
Business Address 700 TECHNOLOGY DRIVE PITTSBURGH PA 15219 6464501790
NeuBase Therapeutics, Inc. (Filer) CIK: 0001173281 (see all company filings)

EIN.: 465622433 | State of Incorp.: DE | Fiscal Year End: 0930
Type: 8-K | Act: 34 | File No.: 001-35963 | Film No.: 20518241
SIC: 2834 Pharmaceutical Preparations